Physician profile

George W Dittrick

Surgical Oncology · Omaha, NE

NPI 1669530630

$8,632.55

in general payments reported to CMS, 2019-2025

32 companies · $1,727 in 2025

The $1,727 reported for 2025 was more than what 79% of Surgical Oncology providers received nationally (typical 2025 total: $288).

See the full distribution for Surgical Oncology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,054.46
Travel and Lodging$1,872.48

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $3,175.88 2021-2025 1788, Spy-Phi System, 1688
Abbvie INC. $1,375.53 2019-2025 Creon
Intuitive Surgical, INC. $874.29 2023-2025 Da Vinci Surgical System
Aimmune Therapeutics, INC. $562.48 2024-2025 Zenpep
Ethicon US, LLC $515.94 2019-2025 Echelon Endopath, Echelon Circular, Echelon Flex
Tela Bio, INC. $474.38 2019-2022
Baxter Healthcare $248.59 2022-2024 Preveleak
Davol INC. $183.85 2023 Phasix Mesh
Atricure, INC. $131.46 2025 Atricure Cryoice Cryosphere Cryoablation System
Olympus America INC. $130.22 2019
Kerecis Limited $123.45 2024-2025 Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose
Nestle Healthcare Nutrition INC. $119.41 2022-2023
Mallinckrodt Enterprises LLC $105.72 2019
Smith+Nephew, INC. $102.44 2019-2024 Stravix Pl, Collagenase Santyl, Oasis
Integra Lifesciences Corporation $63.70 2022-2024 Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim
Show all 32 companies
CompanyGeneral paymentsYearsTop products
Covidien LP $46.39 2019-2020
Conmed Corporation $44.39 2024 Airseal
Dilon Technologies, INC. $40.61 2023 Hemoblast Bellows
Cook Medical LLC $36.42 2019-2020
Vivus LLC $33.97 2020-2024 Pancreaze
Merck Sharp & Dohme LLC $33.63 2019-2020
Alcresta Therapeutics, INC. $32.74 2023 Relizorb
Asensus Surgical, INC. $29.35 2019
Myriad Genetic Laboratories, INC. $23.30 2021
Hologic INC $22.45 2022
Misonix INC $21.39 2020
Melinta Therapeutics, LLC $16.26 2019
Regeneron Healthcare Solutions, INC. $15.68 2025 Libtayo
Tetraphase Pharmaceuticals, INC. $14.00 2019
Allergan, INC. $13.70 2019
Tei Biosciences INC $11.56 2019
Rti Surgical, INC $9.37 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

George W Dittrick

$8,632.55

in general payments reported 2019-2025

Years
2019-2025
Top company
Stryker Corporation
Context
The $1,727 reported for 2025 was more than what 79% of Surgical Oncology providers received nationally (typical 2025 total: $288).

https://glasscript.com/doctor/74966/george-w-dittrick

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.